These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Chemical remodeling of the mycomembrane with chain-truncated lipids sensitizes mycobacteria to rifampicin.
    Author: Gaidhane IV, Biegas KJ, Erickson HE, Agarwal P, Chhonker YS, Ronning DR, Swarts BM.
    Journal: Chem Commun (Camb); 2023 Nov 21; 59(93):13859-13862. PubMed ID: 37929833.
    Abstract:
    The outer mycomembrane of Mycobacterium tuberculosis and related pathogens is a robust permeability barrier that protects against antibiotic treatment. Here, we demonstrate that synthetic analogues of the mycomembrane biosynthetic precursor trehalose monomycolate bearing truncated lipid chains increase permeability of Mycobacterium smegmatis cells and sensitize them to treatment with the first-line anti-tubercular drug rifampicin. The reported strategy may be useful for enhancing entry of drugs and other molecules to mycobacterial cells, and represents a new way to study mycomembrane structure and function.
    [Abstract] [Full Text] [Related] [New Search]